# Harrow, Inc.: filings

HROW · Nasdaq · CIK 1360214 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hrow.md) · [Financials](/companies/hrow/financials.md) · [Filings](/companies/hrow/filings.md) · [Insiders](/companies/hrow/insiders.md)

## Reports and events: 371 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 258, 4 226, 10-Q 53, 3 34, SC 13G/A 32, 10-K 18, SC 13G 18, 424B5 15, DEF 14A 15, 5 9, DEFA14A 8, EFFECT 8, CORRESP 7, SC 13D 7, SC 13D/A 7, 4/A 6, S-3 6, S-8 6, 8-K/A 5, S-1/A 5, UPLOAD 5, D 4, PRE 14A 4, 8-A12B 3, CT ORDER 3, DEF 14C 3, FWP 3, SCHEDULE 13G/A 3, 25-NSE 2, 305B2 2, 424B3 2, CERT 2, NT 10-K 2, PRE 14C 2, S-3/A 2, SEC STAFF LETTER 2, 10-K/A 1, 144 1, 3/A 1, 424B4 1, CERTNAS 1, POS AM 1, S-1 1, S-1MEF 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 07:32 ET | [8-K](/filings/0001628280-26-064749.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-064749 |
| 2026-09-04 | 16:45 ET | [8-K](/filings/0001493152-26-041569.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-041569 |
| 2026-08-10 | 16:28 ET | [10-Q](/filings/0001628280-26-055271.md) | Quarterly report, period 2026-06-30 | 0001628280-26-055271 |
| 2026-08-10 | 16:10 ET | [8-K](/filings/0001493152-26-036865.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036865 |
| 2026-08-06 | 07:15 ET | [8-K](/filings/0001493152-26-036256.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036256 |
| 2026-06-22 | 07:30 ET | [8-K](/filings/0001493152-26-029486.md) | 5.07 Shareholder vote results | 0001493152-26-029486 |
| 2026-06-03 | 09:15 ET | [8-K](/filings/0001493152-26-026983.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-026983 |
| 2026-05-11 | 16:31 ET | [10-Q](/filings/0001493152-26-022254.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022254 |
| 2026-05-11 | 16:10 ET | [8-K](/filings/0001493152-26-022227.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-022227 |
| 2026-04-24 | 16:05 ET | [DEF 14A](/filings/0001493152-26-018912.md) | Proxy statement, period 2025-12-31 | 0001493152-26-018912 |
| 2026-03-27 | 16:05 ET | [8-K](/filings/0001493152-26-013199.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-013199 |
| 2026-03-24 | 16:58 ET | [8-K](/filings/0001493152-26-012389.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-012389 |
| 2026-03-24 | 08:16 ET | [8-K](/filings/0001493152-26-012279.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-012279 |
| 2026-03-10 | 08:26 ET | [8-K](/filings/0001493152-26-009452.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009452 |
| 2026-03-02 | 16:31 ET | [10-K](/filings/0001493152-26-008562.md) | Annual report, period 2025-12-31 | 0001493152-26-008562 |
| 2026-03-02 | 16:15 ET | [8-K](/filings/0001493152-26-008552.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008552 |
| 2026-02-02 | 07:30 ET | [8-K](/filings/0001493152-26-004635.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-004635 |
| 2025-11-18 | 08:00 ET | [8-K](/filings/0001493152-25-023988.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-023988 |
| 2025-11-10 | 17:16 ET | [10-Q](/filings/0001493152-25-021562.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021562 |
| 2025-11-10 | 17:09 ET | [8-K](/filings/0001493152-25-021555.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-021555 |
| 2025-10-06 | 07:23 ET | [8-K](/filings/0001493152-25-017007.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-017007 |
| 2025-10-01 | 07:39 ET | [8-K/A](/filings/0001493152-25-016473.md) | 9.01 Financial statements and exhibits | 0001493152-25-016473 |
| 2025-09-29 | 07:00 ET | [8-K](/filings/0001493152-25-015878.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-25-015878 |
| 2025-09-26 | 16:05 ET | [8-K](/filings/0001493152-25-015712.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-015712 |
| 2025-09-26 | 07:05 ET | [8-K](/filings/0001493152-25-015054.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-015054 |
| 2025-09-19 | 16:05 ET | [8-K](/filings/0001493152-25-014242.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-25-014242 |
| 2025-09-12 | 16:48 ET | [8-K](/filings/0001493152-25-013268.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013268 |
| 2025-09-09 | 07:00 ET | [8-K](/filings/0001493152-25-012840.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-012840 |
| 2025-09-08 | 08:01 ET | [8-K](/filings/0001493152-25-012778.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-012778 |
| 2025-08-25 | 07:07 ET | [8-K](/filings/0001641172-25-025336.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-025336 |
| 2025-08-11 | 16:16 ET | [10-Q](/filings/0001641172-25-022980.md) | Quarterly report, period 2025-06-30 | 0001641172-25-022980 |
| 2025-08-11 | 16:05 ET | [8-K](/filings/0001641172-25-022971.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-022971 |
| 2025-07-17 | 07:16 ET | [8-K](/filings/0001641172-25-019976.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-019976 |
| 2025-06-20 | 06:01 ET | [8-K](/filings/0001641172-25-015665.md) | 5.07 Shareholder vote results | 0001641172-25-015665 |
| 2025-06-09 | 07:05 ET | [8-K](/filings/0001641172-25-014234.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-014234 |
| 2025-05-08 | 16:16 ET | [10-Q](/filings/0001641172-25-009263.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009263 |
| 2025-05-08 | 16:05 ET | [8-K](/filings/0001641172-25-009247.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009247 |
| 2025-04-25 | 08:00 ET | [DEF 14A](/filings/0001641172-25-006102.md) | Proxy statement, period 2024-12-31 | 0001641172-25-006102 |
| 2025-04-07 | 21:54 ET | [SCHEDULE 13D/A](/filings/0001641172-25-003110.md) | Ownership report, active investor, amended | 0001641172-25-003110 |
| 2025-03-27 | 16:05 ET | [10-K](/filings/0001641172-25-000925.md) | Annual report, period 2024-12-31 | 0001641172-25-000925 |
| 2025-03-27 | 16:02 ET | [8-K](/filings/0001641172-25-000915.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-000915 |
| 2025-03-17 | 16:28 ET | [8-K](/filings/0001493152-25-010589.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-010589 |
| 2025-01-21 | 07:00 ET | [8-K](/filings/0001493152-25-002913.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-002913 |
| 2024-11-14 | 06:23 ET | [10-Q](/filings/0001493152-24-045295.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045295 |
| 2024-11-14 | 06:16 ET | [8-K](/filings/0001493152-24-045283.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045283 |
| 2024-10-28 | 07:00 ET | [8-K](/filings/0001493152-24-042600.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-042600 |
| 2024-09-09 | 07:30 ET | [8-K](/filings/0001493152-24-035390.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-035390 |
| 2024-08-07 | 17:15 ET | [10-Q](/filings/0001493152-24-030575.md) | Quarterly report, period 2024-06-30 | 0001493152-24-030575 |
| 2024-08-07 | 16:33 ET | [8-K](/filings/0001493152-24-030563.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-030563 |
| 2024-06-26 | 07:00 ET | [8-K](/filings/0001493152-24-025198.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-24-025198 |

Page 1 of 8. [Older](/companies/hrow/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:30 ET. No prices; not investment advice.